10x Genomics Inc. (TXG) 12-Month Stock Forecast & Price Target Cone
10x Genomics Inc. (TXG) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (-143.8% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Drag to Test Your TXG Position Size: $10,000
Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)
Street Historical Accuracy: 64/100| Wall Street Firm | Stance | 12M Target | 1Y Accuracy | Track Grade |
|---|---|---|---|---|
| Morgan StanleyInstitutional Equity Desk | HOLD | $87 | 74% | A |
| Goldman SachsSector Coverage Lead | BUY | $101 | 69% | B |
| JP MorganUS Large-Cap Research | HOLD | $75 | 58% | C |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TXG)
- ✓Live walkthrough of TXG's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
TXG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TXG today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TXG. Explore sector supply chains on /butterfly.
TXG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhat is TXG's 12-month stock price target?
10x Genomics Inc. (TXG) carries a 12-month consensus base price target of $84.12 (+3.2% from $81.55), with a bull-case target of $107.95 and a bear-case floor of $65.61.
Is TXG stock a Buy, Hold, or Sell right now?
Roarable's 5-Pillar RQD Quant Engine rates TXG D (Sell — SELL) with an RQD Confidence score of 65/100.